Product Information

LOFEXIDINE 0.18 MG TABLET is a generic product labeled by Prasco Laboratories, priced at $7.4718 per EA under NDC 66993034537. Its NADAC has been published 101 times since Dec 18, 2024.

FDA first approved this application on May 16, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LOFEXIDINE 0.18 MG TABLET

lofexidine hydrochloride
$7.4718per EA

Strength

.2 mg/1

NDC

66993034537

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LOFEXIDINE HYDROCHLORIDE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA209229

FDA Approved

5/16/2018

TE Code

AB

On Market Since

8/29/2024

Price Statistics

The NADAC for LOFEXIDINE 0.18 MG TABLET has been published 101 times since Dec 18, 2024, and over the history we have for it it has declined 42.0%. The table below summarizes its recorded NADAC range and movement.

Current price$7.4718 per EA
All-time high$12.9814 (Sep 10, 2025)
All-time low$7.3933 (Oct 21, 2026)
52-week high$10.7855
52-week low$7.3933
Median price$10.7855
Average price$10.9052
Largest weekly change-9.3% (Oct 22, 2025)
Weeks tracked101
Tracking sinceDec 18, 2024

Price History

1W

+1.1%

1M

+1.1%

3M

-13.7%

6M

-27.4%

1Y

-28.9%

3Y

N/A

5Y

N/A

All

-42.0%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LOFEXIDINE 0.18 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LOFEXIDINE 0.18 MG TABLET, manufactured by Prasco Laboratories, is $7.4718 per EA (NDC 66993034537), effective Nov 18, 2026.

How has the price of LOFEXIDINE 0.18 MG TABLET changed over time?

Over the history we have for it, the NADAC for LOFEXIDINE 0.18 MG TABLET has declined 42.0%. It has been tracked across 101 weekly CMS publications since Dec 18, 2024.

What are the highest and lowest recorded NADAC prices for LOFEXIDINE 0.18 MG TABLET?

Since Dec 18, 2024, the NADAC for LOFEXIDINE 0.18 MG TABLET has ranged from a low of $7.3933 (Oct 21, 2026) to a high of $12.9814 (Sep 10, 2025), with a median of $10.7855 per EA.

Are there cheaper alternatives to LOFEXIDINE 0.18 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOFEXIDINE 0.18 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures LOFEXIDINE 0.18 MG TABLET?

LOFEXIDINE 0.18 MG TABLET (NDC 66993034537) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.